Innovative AAV Production Process Funded by NIIMBL Grant: ChromaTan and Landmark Bio Collaborate ChromaTan and Landmark Bio receive NIIMBL funding to enhance AAV production for gene therapy. A significant step towards accessible treatments.

Innovative AAV Production Process Funded by NIIMBL Grant: ChromaTan and Landmark Bio Collaborate #United_States #NIIMBL #ChromaTan #Landmark_Bio #Spring_House,_Watertown